Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 33.60
+1.10 (3.38%)
Apr 24, 2026, 1:44 PM IDT
TLV:CBI Market Cap
TLV:CBI has a market cap or net worth of 52.7 million as of April 24, 2026. Its market cap has decreased by -2.04% in one year.
Market Cap
52.70M
Enterprise Value
71.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
33.60
Market Cap Chart
Since July 23, 2007, TLV:CBI's market cap has decreased from 797.05M to 52.70M, a decrease of -93.39%. That is a compound annual growth rate of -13.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 50.98M | 6.91% |
| Dec 31, 2025 | 47.68M | -12.89% |
| Dec 31, 2024 | 54.74M | -12.09% |
| Dec 31, 2023 | 62.27M | -36.78% |
| Dec 29, 2022 | 98.50M | -46.87% |
| Dec 30, 2021 | 185.39M | -41.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 495.29M |
| Geffen Residence & Renewal | 257.44M |
| Matricelf | 92.74M |
| BioLineRx | 33.94M |
| Evogene | 29.17M |
| Can-Fite BioPharma | 19.82M |
| BioLight Life Sciences | 19.45M |
| XTL Biopharmaceuticals | 18.92M |